Neupro Approval History
FDA Approved: Yes (First approved May 9, 2007)
Brand name: Neupro
Generic name: rotigotine
Dosage form: Transdermal System
Company: Schwarz Pharma
Treatment for: Parkinson's Disease, Restless Legs Syndrome
Neupro (rotigotine) is a dopamine agonist transdermal system indicated for the treatment of Parkinson’s disease and Restless Legs Syndrome.
Development History and FDA Approval Process for Neupro
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.